<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37962360</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2150-7511</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>19</Day></PubDate></JournalIssue><Title>mBio</Title><ISOAbbreviation>mBio</ISOAbbreviation></Journal><ArticleTitle>Early enterovirus translation deficits extend viral RNA replication and elicit sustained MDA5-directed innate signaling.</ArticleTitle><Pagination><StartPage>e0191523</StartPage><MedlinePgn>e0191523</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e01915-23</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/mbio.01915-23</ELocationID><Abstract><AbstractText>Multiple pattern recognition receptors sense vRNAs and initiate downstream innate signaling: endosomal Toll-like receptors (TLRs) 3, 7, and 8 and cytoplasmic RIG-I-like receptors (RLRs) RIG-I, and MDA5. They engage distinct signaling scaffolds: mitochondrial antiviral signaling protein (RLR), MyD88, and TLR-adaptor interacting with SLC15A4 on the lysosome (TLR7 and TLR8) and toll/IL-1R domain-containing adaptor inducing IFN (TLR3). By virtue of their unusual vRNA structure and direct host cell entry path, the innate response to EVs uniquely is orchestrated by MDA5. We reported that PVSRIPO's profound attenuation and loss of cytopathogenicity triggers MDA5-directed polar TBK1-IRF3 signaling that generates priming of polyfunctional antitumor CD8<sup>+</sup> T-cell responses and durable antitumor surveillance <i>in vivo</i>. Here we unraveled EV-host relations that control suppression of host type-I IFN responses and show that PVSRIPO's deficient immediate host eIF4G cleavage generates unopposed MDA5-directed downstream signaling cascades resulting in sustained type-I IFN release.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dobrikov</LastName><ForeName>Mikhail I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Duke University Medical School, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobrikova</LastName><ForeName>Elena Y</ForeName><Initials>EY</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Duke University Medical School, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nardone-White</LastName><ForeName>Dasean T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Duke University Medical School, Durham, North Carolina, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics and Microbiology, Duke University Medical School, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKay</LastName><ForeName>Zachary P</ForeName><Initials>ZP</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Duke University Medical School, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Michael C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Duke University Medical School, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gromeier</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4538-0302</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Duke University Medical School, Durham, North Carolina, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics and Microbiology, Duke University Medical School, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R00 CA263021</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA281320</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS108773</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K99 CA263021</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F32 CA224593</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS108773</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F32 CA224593</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R00 CA263021</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA281320</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>mBio</MedlineTA><NlmUniqueID>101519231</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D000072640">Interferon-Induced Helicase, IFIH1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C452815">IFIH1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050838">Interferon Regulatory Factor-3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000072640" MajorTopicYN="Y">Interferon-Induced Helicase, IFIH1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="Y">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="Y">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014176" MajorTopicYN="N">Protein Biosynthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050838" MajorTopicYN="N">Interferon Regulatory Factor-3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094405" MajorTopicYN="N">RNA Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IRF3</Keyword><Keyword MajorTopicYN="N">MDA5</Keyword><Keyword MajorTopicYN="N">eIF4G</Keyword><Keyword MajorTopicYN="N">interferon</Keyword><Keyword MajorTopicYN="N">poliovirus</Keyword></KeywordList><CoiStatement>M.G. holds equity in, is a paid consultant of, and is inventor of intellectual property licensed to Istari Oncology, Inc. M.C.B. is a paid consultant of and an inventor of intellectual property licensed to Istari Oncology, Inc. All other authors report no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>28</Day><Hour>14</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>14</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>14</Day><Hour>9</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37962360</ArticleId><ArticleId IdType="pmc">PMC10746184</ArticleId><ArticleId IdType="doi">10.1128/mbio.01915-23</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Feng Q, Hato SV, Langereis MA, Zoll J, Virgen-Slane R, Peisley A, Hur S, Semler BL, van Rij RP, van Kuppeveld FJM. 2012. MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell Rep 2:1187–1196. doi:10.1016/j.celrep.2012.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.10.005</ArticleId><ArticleId IdType="pmc">PMC7103987</ArticleId><ArticleId IdType="pubmed">23142662</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh C-S, Reis e Sousa C, Matsuura Y, Fujita T, Akira S. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101–105. doi:10.1038/nature04734</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04734</ArticleId><ArticleId IdType="pubmed">16625202</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo Y-M, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, García-Sastre A, Katze MG, Gale M. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82:335–345. doi:10.1128/JVI.01080-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01080-07</ArticleId><ArticleId IdType="pmc">PMC2224404</ArticleId><ArticleId IdType="pubmed">17942531</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YF, Nomoto A, Detjen BM, Wimmer E. 1977. A protein covalently linked to poliovirus genome RNA. Proc Natl Acad Sci U S A 74:59–63. doi:10.1073/pnas.74.1.59</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.74.1.59</ArticleId><ArticleId IdType="pmc">PMC393196</ArticleId><ArticleId IdType="pubmed">189316</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelletier J, Sonenberg N. 1988. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334:320–325. doi:10.1038/334320a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/334320a0</ArticleId><ArticleId IdType="pubmed">2839775</ArticleId></ArticleIdList></Reference><Reference><Citation>Gingras AC, Raught B, Sonenberg N. 1999. EIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68:913–963. doi:10.1146/annurev.biochem.68.1.913</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.68.1.913</ArticleId><ArticleId IdType="pubmed">10872469</ArticleId></ArticleIdList></Reference><Reference><Citation>Etchison D, Milburn SC, Edery I, Sonenberg N, Hershey JW. 1982. Inhibition of Hela cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J Biol Chem 257:14806–14810.</Citation><ArticleIdList><ArticleId IdType="pubmed">6294080</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamphear BJ, Kirchweger R, Skern T, Rhoads RE. 1995. Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases. Implications for cap-dependent and cap-independent translational initiation. J Biol Chem 270:21975–21983. doi:10.1074/jbc.270.37.21975</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.37.21975</ArticleId><ArticleId IdType="pubmed">7665619</ArticleId></ArticleIdList></Reference><Reference><Citation>de Breyne S, Yu Y, Unbehaun A, Pestova TV, Hellen CUT. 2009. Direct functional interaction of initiation factor eIF4G with type 1 internal ribosomal entry sites. Proc Natl Acad Sci U S A 106:9197–9202. doi:10.1073/pnas.0900153106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0900153106</ArticleId><ArticleId IdType="pmc">PMC2695064</ArticleId><ArticleId IdType="pubmed">19470487</ArticleId></ArticleIdList></Reference><Reference><Citation>Gromeier M, Lachmann S, Rosenfeld MR, Gutin PH, Wimmer E. 2000. Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc Natl Acad Sci U S A 97:6803–6808. doi:10.1073/pnas.97.12.6803</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.97.12.6803</ArticleId><ArticleId IdType="pmc">PMC18745</ArticleId><ArticleId IdType="pubmed">10841575</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MC, Holl EK, Boczkowski D, Dobrikova E, Mosaheb M, Chandramohan V, Bigner DD, Gromeier M, Nair SK. 2017. Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs. Sci Transl Med 9:eaan4220. doi:10.1126/scitranslmed.aan4220</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aan4220</ArticleId><ArticleId IdType="pmc">PMC6034685</ArticleId><ArticleId IdType="pubmed">28931654</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MC, Mosaheb MM, Mohme M, McKay ZP, Holl EK, Kastan JP, Yang Y, Beasley GM, Hwang ES, Ashley DM, Bigner DD, Nair SK, Gromeier M. 2021. Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling. Nat Commun 12:1858. doi:10.1038/s41467-021-22088-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22088-1</ArticleId><ArticleId IdType="pmc">PMC7994570</ArticleId><ArticleId IdType="pubmed">33767151</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherer WF, Syverton JT, Gey GO. 1953. Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J Exp Med 97:695–710. doi:10.1084/jem.97.5.695</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.97.5.695</ArticleId><ArticleId IdType="pmc">PMC2136303</ArticleId><ArticleId IdType="pubmed">13052828</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang P, Faase JAJ, Toyoda H, Paul A, Wimmer E, Gorbalenya AE. 2007. Evidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradication. Proc Natl Acad Sci U S A 104:9457–9462. doi:10.1073/pnas.0700451104</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0700451104</ArticleId><ArticleId IdType="pmc">PMC1874223</ArticleId><ArticleId IdType="pubmed">17517601</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufresne AT, Gromeier M. 2004. A nonpolio enterovirus with respiratory tropism causes poliomyelitis in intercellular adhesion molecule 1 transgenic mice. Proc Natl Acad Sci U S A 101:13636–13641. doi:10.1073/pnas.0403998101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0403998101</ArticleId><ArticleId IdType="pmc">PMC518806</ArticleId><ArticleId IdType="pubmed">15353596</ArticleId></ArticleIdList></Reference><Reference><Citation>Gromeier M, Alexander L, Wimmer E. 1996. Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants. Proc Natl Acad Sci U S A 93:2370–2375. doi:10.1073/pnas.93.6.2370</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.6.2370</ArticleId><ArticleId IdType="pmc">PMC39803</ArticleId><ArticleId IdType="pubmed">8637880</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagaraj N, Wisniewski JR, Geiger T, Cox J, Kircher M, Kelso J, Pääbo S, Mann M. 2011. Deep proteome and transcriptome mapping of a human cancer cell line. Mol Syst Biol 7:548. doi:10.1038/msb.2011.81</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/msb.2011.81</ArticleId><ArticleId IdType="pmc">PMC3261714</ArticleId><ArticleId IdType="pubmed">22068331</ArticleId></ArticleIdList></Reference><Reference><Citation>Kastan JP, Tremblay MW, Brown MC, Trimarco JD, Dobrikova EY, Dobrikov MI, Gromeier M. 2021. Enterovirus 2A(pro) cleavage of the YTHDF m(6)A readers implicates YTHDF3 as a mediator of type I interferon-driven JAK/STAT signaling. mBio 12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8092205</ArticleId><ArticleId IdType="pubmed">33849973</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrikov MI, Dobrikova EY, McKay ZP, Kastan JP, Brown MC, Gromeier M. 2022. PKR binds enterovirus IRESs, displaces host translation factors, and impairs viral translation to enable innate antiviral signaling. mBio 13:e0085422. doi:10.1128/mbio.00854-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00854-22</ArticleId><ArticleId IdType="pmc">PMC9239082</ArticleId><ArticleId IdType="pubmed">35652592</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosaheb MM, Dobrikova EY, Brown MC, Yang Y, Cable J, Okada H, Nair SK, Bigner DD, Ashley DM, Gromeier M. 2020. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. Nat Commun 11:524. doi:10.1038/s41467-019-13939-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13939-z</ArticleId><ArticleId IdType="pmc">PMC6985231</ArticleId><ArticleId IdType="pubmed">31988324</ArticleId></ArticleIdList></Reference><Reference><Citation>Walton RW, Brown MC, Sacco MT, Gromeier M. 2018. Engineered oncolytic poliovirus PVSRIPO subverts MDA5-dependent innate immune responses in cancer cells. J Virol 92:e00879-18. doi:10.1128/JVI.00879-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00879-18</ArticleId><ArticleId IdType="pmc">PMC6146809</ArticleId><ArticleId IdType="pubmed">29997212</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, Matsushita K, Hiiragi A, Dermody TS, Fujita T, Akira S. 2008. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205:1601–1610. doi:10.1084/jem.20080091</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20080091</ArticleId><ArticleId IdType="pmc">PMC2442638</ArticleId><ArticleId IdType="pubmed">18591409</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittling MC, Cahalan SR, Levenson EA, Rabin RL. 2020. Shared and unique features of human interferon-beta and interferon-alpha subtypes. Front Immunol 11:605673. doi:10.3389/fimmu.2020.605673</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.605673</ArticleId><ArticleId IdType="pmc">PMC7850986</ArticleId><ArticleId IdType="pubmed">33542718</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner SM, Wiehler S, Michi AN, Proud D. 2019. Rhinovirus replication and innate immunity in highly differentiated human airway epithelial cells. Respir Res 20:150. doi:10.1186/s12931-019-1120-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-019-1120-0</ArticleId><ArticleId IdType="pmc">PMC6626354</ArticleId><ArticleId IdType="pubmed">31299975</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13:539–548. doi:10.1016/s1074-7613(00)00053-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1074-7613(00)00053-4</ArticleId><ArticleId IdType="pubmed">11070172</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen L, Chen CY, Huang D, Wang R, Zhang M, Qian L, Zhu Y, Zhang AZ, Yang E, Qaqish A, Chumakov K, Kouiavskaia D, Vignuzzi M, Nathanson N, Macadam AJ, Andino R, Kew O, Xu J, Chen ZW. 2017. Pathogenic events in a nonhuman primate model of oral poliovirus infection leading to paralytic poliomyelitis. J Virol 91:e02310-16. doi:10.1128/JVI.02310-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02310-16</ArticleId><ArticleId IdType="pmc">PMC5487571</ArticleId><ArticleId IdType="pubmed">28356537</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahid R, Cannon MJ, Chow M. 2005. Dendritic cells and macrophages are productively infected by poliovirus. J Virol 79:401–409. doi:10.1128/JVI.79.1.401-409.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.1.401-409.2005</ArticleId><ArticleId IdType="pmc">PMC538697</ArticleId><ArticleId IdType="pubmed">15596833</ArticleId></ArticleIdList></Reference><Reference><Citation>Kräusslich HG, Nicklin MJ, Toyoda H, Etchison D, Wimmer E. 1987. Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide P220. J Virol 61:2711–2718. doi:10.1128/JVI.61.9.2711-2718.1987</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.61.9.2711-2718.1987</ArticleId><ArticleId IdType="pmc">PMC255777</ArticleId><ArticleId IdType="pubmed">3039165</ArticleId></ArticleIdList></Reference><Reference><Citation>Serganov AA, Udi Y, Stein ME, Patel V, Fridy PC, Rice CM, Saeed M, Jacobs EY, Chait BT, Rout MP. 2022. Proteomic elucidation of the targets and primary functions of the picornavirus 2A protease. J Biol Chem 298:101882. doi:10.1016/j.jbc.2022.101882</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2022.101882</ArticleId><ArticleId IdType="pmc">PMC9168619</ArticleId><ArticleId IdType="pubmed">35367208</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicklin MJ, Kräusslich HG, Toyoda H, Dunn JJ, Wimmer E. 1987. Poliovirus polypeptide precursors: expression in vitro and processing by exogenous 3C and 2A proteinases. Proc Natl Acad Sci U S A 84:4002–4006. doi:10.1073/pnas.84.12.4002</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.84.12.4002</ArticleId><ArticleId IdType="pmc">PMC305009</ArticleId><ArticleId IdType="pubmed">3035560</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyoda H, Nicklin MJ, Murray MG, Anderson CW, Dunn JJ, Studier FW, Wimmer E. 1986. A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell 45:761–770. doi:10.1016/0092-8674(86)90790-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(86)90790-7</ArticleId><ArticleId IdType="pubmed">3011278</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu N-Y, Ilnytska O, Belov G, Santiana M, Chen Y-H, Takvorian PM, Pau C, van der Schaar H, Kaushik-Basu N, Balla T, Cameron CE, Ehrenfeld E, van Kuppeveld FJM, Altan-Bonnet N. 2010. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 141:799–811. doi:10.1016/j.cell.2010.03.050</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.03.050</ArticleId><ArticleId IdType="pmc">PMC2982146</ArticleId><ArticleId IdType="pubmed">20510927</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrikova EY, Grisham RN, Kaiser C, Lin J, Gromeier M. 2006. Competitive translation efficiency at the picornavirus type 1 internal ribosome entry site facilitated by viral cis and trans factors. J Virol 80:3310–3321. doi:10.1128/JVI.80.7.3310-3321.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.7.3310-3321.2006</ArticleId><ArticleId IdType="pmc">PMC1440366</ArticleId><ArticleId IdType="pubmed">16537598</ArticleId></ArticleIdList></Reference><Reference><Citation>Dragovich PS, Prins TJ, Zhou R, Webber SE, Marakovits JT, Fuhrman SA, Patick AK, Matthews DA, Lee CA, Ford CE, Burke BJ, Rejto PA, Hendrickson TF, Tuntland T, Brown EL, Meador JW, Ferre RA, Harr JE, Kosa MB, Worland ST. 1999. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease Inhibitors4. Incorporation of P1 lactam moieties as L-glutamine replacements. J Med Chem 42:1213–1224. doi:10.1021/jm9805384</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm9805384</ArticleId><ArticleId IdType="pubmed">10197965</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustin KE, Sarnow P. 2001. Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition. EMBO J 20:240–249. doi:10.1093/emboj/20.1.240</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/20.1.240</ArticleId><ArticleId IdType="pmc">PMC140206</ArticleId><ArticleId IdType="pubmed">11226174</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrd MP, Zamora M, Lloyd RE. 2002. Generation of multiple Isoforms of eukaryotic translation initiation factor 4GI by use of alternate translation initiation codons. Mol Cell Biol 22:4499–4511. doi:10.1128/MCB.22.13.4499-4511.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.22.13.4499-4511.2002</ArticleId><ArticleId IdType="pmc">PMC133909</ArticleId><ArticleId IdType="pubmed">12052860</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholtissek C. 1968. Studies on the uptake of nucleic acid precursors into cells in tissue culture. Biochim Biophys Acta 158:435–447. doi:10.1016/0304-4165(68)90297-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-4165(68)90297-3</ArticleId><ArticleId IdType="pubmed">5660105</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonew M, Tonew E, Mentel R. 1977. The antiviral activity of dipyridamole. Acta Virol 21:146–150.</Citation><ArticleIdList><ArticleId IdType="pubmed">17283</ArticleId></ArticleIdList></Reference><Reference><Citation>Glaser W, Skern T. 2000. Extremely efficient cleavage of eIF4G by picornaviral proteinases L and 2A in vitro. FEBS Lett 480:151–155. doi:10.1016/s0014-5793(00)01928-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0014-5793(00)01928-1</ArticleId><ArticleId IdType="pubmed">11034318</ArticleId></ArticleIdList></Reference><Reference><Citation>Gromeier M, Bossert B, Arita M, Nomoto A, Wimmer E. 1999. Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. J Virol 73:958–964. doi:10.1128/JVI.73.2.958-964.1999</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.2.958-964.1999</ArticleId><ArticleId IdType="pmc">PMC103915</ArticleId><ArticleId IdType="pubmed">9882296</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57–70. doi:10.1016/s0092-8674(00)81683-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(00)81683-9</ArticleId><ArticleId IdType="pubmed">10647931</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MC, Bryant JD, Dobrikova EY, Shveygert M, Bradrick SS, Chandramohan V, Bigner DD, Gromeier M. 2014. Induction of viral, 7-methyl-guanosine cap-independent translation and oncolysis by mitogen-activated protein kinase-interacting kinase-mediated effects on the serine/arginine-rich protein kinase. J Virol 88:13135–13148. doi:10.1128/JVI.01883-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01883-14</ArticleId><ArticleId IdType="pmc">PMC4249076</ArticleId><ArticleId IdType="pubmed">25187541</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MC, Dobrikov MI, Gromeier M. 2014. Mitogen-activated protein kinase-interacting kinase regulates mTOR/AKT signaling and controls the serine/arginine-rich protein kinase-responsive type 1 internal ribosome entry site-mediated translation and viral oncolysis. J Virol 88:13149–13160. doi:10.1128/JVI.01884-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01884-14</ArticleId><ArticleId IdType="pmc">PMC4249080</ArticleId><ArticleId IdType="pubmed">25187540</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrikov M, Dobrikova E, Shveygert M, Gromeier M. 2011. Phosphorylation of eukaryotic translation initiation factor 4G1 (eIF4G1) by protein kinase C{alpha} regulates eIF4G1 binding to Mnk1. Mol Cell Biol 31:2947–2959. doi:10.1128/MCB.05589-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.05589-11</ArticleId><ArticleId IdType="pmc">PMC3133411</ArticleId><ArticleId IdType="pubmed">21576361</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrikov MI, Dobrikova EY, Gromeier M. 2013. Dynamic regulation of the translation initiation helicase complex by mitogenic signal transduction to eukaryotic translation initiation factor 4G. Mol Cell Biol 33:937–946. doi:10.1128/MCB.01441-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01441-12</ArticleId><ArticleId IdType="pmc">PMC3623071</ArticleId><ArticleId IdType="pubmed">23263986</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrikov MI, Dobrikova EY, Gromeier M. 2018. Ribosomal RACK1: protein kinase C ΒII modulates intramolecular interactions between unstructured regions of eukaryotic initiation factor 4G (eIF4G) that control eIF4E and eIF3 binding. Mol Cell Biol 38:e00306-18. doi:10.1128/MCB.00306-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00306-18</ArticleId><ArticleId IdType="pmc">PMC6146829</ArticleId><ArticleId IdType="pubmed">30012864</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrikov MI, Dobrikova EY, Gromeier M.. 2018. Ribosomal RACK1:PKCbetaII phosphorylates eIF4G1(S1093) to modulate cap-dependent and -independent translation initiation. Mol Cell Biol doi:10.1128/MCB.00304-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00304-18</ArticleId><ArticleId IdType="pmc">PMC6146833</ArticleId><ArticleId IdType="pubmed">30012863</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetz C, Everson RG, Zhang LC, Gromeier M. 2010. MAPK signal-integrating kinase controls cap-independent translation and cell type-specific cytotoxicity of an oncolytic poliovirus. Mol Ther 18:1937–1946. doi:10.1038/mt.2010.145</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2010.145</ArticleId><ArticleId IdType="pmc">PMC2990508</ArticleId><ArticleId IdType="pubmed">20648000</ArticleId></ArticleIdList></Reference><Reference><Citation>Shveygert M, Kaiser C, Bradrick SS, Gromeier M. 2010. Regulation of eukaryotic initiation factor 4E (eIF4E) phosphorylation by mitogen-activated protein kinase occurs through modulation of Mnk1-eIF4G interaction. Mol Cell Biol 30:5160–5167. doi:10.1128/MCB.00448-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00448-10</ArticleId><ArticleId IdType="pmc">PMC2953056</ArticleId><ArticleId IdType="pubmed">20823271</ArticleId></ArticleIdList></Reference><Reference><Citation>Desjardins A, Gromeier M, Herndon JE, Beaubier N, Bolognesi DP, Friedman AH, Friedman HS, McSherry F, Muscat AM, Nair S, Peters KB, Randazzo D, Sampson JH, Vlahovic G, Harrison WT, McLendon RE, Ashley D, Bigner DD. 2018. Recurrent glioblastoma treated with recombinant poliovirus. N Engl J Med 379:150–161. doi:10.1056/NEJMoa1716435</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1716435</ArticleId><ArticleId IdType="pmc">PMC6065102</ArticleId><ArticleId IdType="pubmed">29943666</ArticleId></ArticleIdList></Reference><Reference><Citation>Beasley GM, Brown MC, Farrow NE, Landa K, Al-Rohil RN, Selim MA, Therien AD, Jung SH, Gao J, Boczkowski D, Holl EK, Salama AKS, Bigner DD, Gromeier M, Nair SK. 2022. Multimodality analysis confers a prognostic benefit of a T-cell infiltrated tumor microenvironment and peripheral immune status in patients with melanoma. J Immunother Cancer 10:e005052. doi:10.1136/jitc-2022-005052</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2022-005052</ArticleId><ArticleId IdType="pmc">PMC9528663</ArticleId><ArticleId IdType="pubmed">36175036</ArticleId></ArticleIdList></Reference><Reference><Citation>Beasley GM, Nair SK, Farrow NE, Landa K, Selim MA, Wiggs CA, Jung SH, Bigner DD, True Kelly A, Gromeier M, Salama AK. 2021. Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma. J Immunother Cancer 9:e002203. doi:10.1136/jitc-2020-002203</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2020-002203</ArticleId><ArticleId IdType="pmc">PMC8057552</ArticleId><ArticleId IdType="pubmed">33875611</ArticleId></ArticleIdList></Reference><Reference><Citation>Kastan JP, Dobrikova EY, Bryant JD, Gromeier M. 2020. CReP mediates selective translation initiation at the endoplasmic reticulum. Sci Adv 6:eaba0745. doi:10.1126/sciadv.aba0745</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aba0745</ArticleId><ArticleId IdType="pmc">PMC7269655</ArticleId><ArticleId IdType="pubmed">32537501</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>